#HVO hVIVO PLC – Annual Report & Notice of AGM April 17, 2026 – Posted in: hVIVO (HVO) – Tags: , , , ,

London, UK – 17 April 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2025 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.

 

The 2025 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website: www.hvivo.com.

 

The Annual General Meeting will be held at the offices of DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF, United Kingdom on 13 May 2026 at 11.00am BST.

 

For further information please contact:

 

hVIVO plc

+44 (0)20 7756 1300

Yamin ‘Mo’ Khan, Chief Executive Officer

Stephen Pinkerton, Chief Financial Officer

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

+44 (0)20 7220 0500

Geoff Nash, Callum Davidson
Trisyia Jamaludin, Harriet Ward

Nigel Birks – Life Science Specialist Sales

Louise Talbot – Sales

Peel Hunt LLP (Joint Broker)

+44 (0)20 7418 8900

James Steel, Dr Christopher Golden

Davy (Joint Broker)

+353 (0) 1 679 6363

Anthony Farrell, Niall Gilchrist

ICR Healthcare (Financial PR & IR)

Mary-Jane Elliott / Stephanie Cuthbert / Phillip Marriage / Louis Ashe-Jepson

 

hVIVO@icrhealthcare.com